Alcon, the global leader in eye care, announced an agreement that provides Alcon exclusive rights to sell the BlephEx® technology and accompanying products in the U.S. The partnership with BlephEx, LLC, the pioneer in bacterial biofilm theory, demonstrates Alcon’s ongoing commitment to bringing forth transformative innovations for eye care practices. The BlephEx eyelid cleaning device and LashCam™ iR WIFI camera will join Alcon’s innovative Systane® iLux® technology in meeting the in-office, ocular surface health needs of patients.
”Since launch, Systane iLux and the wrap-around support programs have provided practice and patient benefits around the country,” said Fred Ellis, Head of Dry Eye Devices at Alcon. “While this has been a great source of pride for Alcon, we want to continue providing solutions that help Eye Care Professionals address a range of ocular surface issues. Our partnership with BlephEx will increase in-office options during a time when we are seeing more ocular surface issues, and put another tool in the arsenal to address unmet patient needs.”
The BlephEx handpiece is a micro-blepharoexfoliation device that spins a soft medical grade micro-sponge along the edge of the eyelids and lashes, removing scurf and debris. This in-office procedure lasts 6 to 8 minutes and has been shown to effectively remove accumulated debris and bacterial biofilm from the eyelid surface.1 The LashCam iR, a WIFI camera with infrared light that instantly transmits hi-res 80X magnification images of eyelid margins, will complement both the BlephEx and Systane iLux procedures by allowing doctors to show patients their meibomian gland structure to aid with patient education.
“Addressing Meibomian Gland Dysfunction (MGD) is a significant unmet need for the anterior segment Eye Care Professional,” said Dr. Eric Donnenfeld,* ophthalmologist, Ophthalmic Consultants of Connecticut. “Systane iLux and BlephEx are perfect partners because removing debris and bacterial biofilm on the eyelid margin and unclogging meibomian glands through thermal pulsation are effective for supporting ocular health and treating MGD, respectively.”
The BlephEx and LashCam iR devices can be purchased alongside the Systane iLux MGD Treatment System, which includes:
- Systane iLux device
- Dry Eye Excellence Program (DEEP™) for practice support
- SystaneMyEyes® patient retention program, including an iLux patient care kit
- Patient education information at GetToRootCause.com
- Professional product information at SystaneiLux.com
“The incidence of ocular surface health issues in the U.S. is significant and can impact almost every area of my practice,” said Dr. Paul Karpecki,* optometrist, Keplr Vision. “Supporting the ocular surface has immeasurable benefits for patient clinical outcomes, and Systane iLux and BlephEx will be beneficial for patients managing ocular surface health.”
For more information, visit SystaneiLux.com, contact your Alcon sales representative or email us at [email protected].
Important Product Information on Systane iLux
Indication: The iLux device is indicated for the application of localized heat and pressure therapy in adult patients with chronic disease of the eyelids, including Meibomian Gland Dysfunction (MGD), also known as evaporative dry eye.
Contraindications: Do NOT use the iLux device in patients with the following conditions: Patients whose pupils have been pharmaceutically dilated; patients who have undergone ocular surgery within prior 12 months; patients with ocular injury or trauma, chemical burns, or limbal stem cell deficiency (within prior 3 months); patients with active ocular herpes zoster or simplex of eye or eyelid or a history of these within prior 3 months; patients with cicatricial lid margin disease; patients with active ocular infection, active ocular inflammation or history of chronic, recurrent ocular inflammation within prior 3 months; patients with an ocular surface abnormality that may compromise corneal integrity; patients with lid surface abnormalities that affect lid function in either eye; patients with aphakia; or, patients with permanent makeup or tattoos on their eyelids.
Warnings/Precautions: Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner. The Disposable may not fit all eyes, such as eyes with small palpebral fornices. Use of the iLux device is NOT recommended in patients with the following conditions: moderate to severe allergic, vernal or giant papillary conjunctivitis; severe eyelid inflammation; systemic disease conditions that cause dry eye; in patients who are taking medications known to cause dryness; or, patients with punctal plugs.
Potential Adverse Reactions: Potential adverse effects may include eyelid/eye pain requiring discontinuation of the treatment procedure, eyelid irritation or inflammation, temporary reddening of the skin, ocular surface irritation or inflammation (e.g., corneal abrasion, conjunctive edema or conjunctival injection (hyperemia)), and ocular symptoms (e.g., burning, stinging, tearing, itching, discharge, redness, foreign body sensation, visual disturbance, sensitivity to light).
Attention: Please refer to the User Manual for a complete list of contraindications, instructions for use, warnings and precautions for the iLux device.
Important Product Information on BlephEx
Indication: BlephEx is intended for exfoliation and debridement of the eyelid margin, from the lash line back to the orifices of the meibomian glands.
Warnings/Precautions: Federal law restricts this device to sale by or on the order of a Physician or Optometrist. Only ophthalmologists, optometrists and their trained staff are authorized to use the device. Failure to follow operating instructions could result in serious injury, including (but not limited to) injury of an eye. Avoid direct, prolonged contact with the eyeball and palpebral conjunctiva. Instill numbing drops into both of your patient’s eyes prior to use.
Attention: Please refer to the User Manual for a complete list of safety instructions and instructions for use for BlephEx. BlephEx is used to remove excess debris on the eyelid margin by a health care professional. Numbing drops will be put into your eyes before treatment with BlephEx.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 23,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.
*Drs. Donnenfeld and Karpecki are paid Alcon consultants.
- Siddireddy JS, Vijay AK, Tan J, Willcox M. Effect of Eyelid Treatments on Bacterial Load and Lipase Activity in Relation to Contact Lens Discomfor. Eye & contact lens. 2020 Jul 1;46(4):245-53.